ELPIS II top-line trial results are anticipated in the third quarter of 2026Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated if ELPIS II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results